Hoane MR | OMICS International
ISSN: 2167-065X

Clinical Pharmacology & Biopharmaceutics
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 312

Clinical Pharmacology & Biopharmaceutics received 312 citations as per google scholar report

Clinical Pharmacology & Biopharmaceutics peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Genamics JournalSeek
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Publons
  • Euro Pub
Share This Page

Hoane MR

Hoane MR Restorative Neuroscience
Laboratory Department of Psychology
Life Science II MC 6502,
Southern Illinois University
Carbondale, IL, 62901, USA


Dr. Michael Hoane received his Ph.D. in Behavioral Neuroscience from Texas Christian University in 1996. His post-doctoral training in neuroscience was conducted at Emory University School of Medicine, CytoTherapeutics, and the Northwestern University School of Medicine. The mission of his Restorative Neuroscience Laboratory is to use state of the art preclinical technologies to develop treatments for traumatic brain injuries (TBI). Within the framework of developing these treatments he also is investigating the pathophysiological and neural plastic changes that occur in the brain following injury, especially those associated with age. Currently, a variety of animal models are used in his laboratory to accomplish these goals and to investigate the ability of novel therapies to facilitate recovery of function on a wide range of behavioral and histological assays. One of his current, and most active, lines of research includes the examination of the preclinical efficacy of various vita-nutrient therapies (e.g., B-vitamins) and other novel compounds following traumatic brain injury. Another major research interest is the continued development and refinement of our preclinical animal models of TBI to increase their potential translatability to the human TBI condition, which includes the examination of frontal lobe mediated behaviors and cognition. In addition, his laboratory is beginning to examine the role of rehabilitative strategies and aging following TBI.

Research Interest

effects of vita-nutrients in brain injury and neurodegenerative diseases

Global Speakers in the subject

Global Experts in the subject